Immunotherapy drug shows unprecedented results in advanced lung cancer
In the largest study of its kind to use immunotherapy to treat lung cancer, UCLA researchers have found that the drug pembrolizumab (Keytrudaź), recently approved by the FDA to treat melanoma, is safe and effective in arresting tumor growth in patients with advanced NSCLC. April 19, 2015